Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
NASDAQ
Unprofitable
Unprofitable
309M
Biotechnology
Next Earning date - 07 May 2025
309M
Biotechnology
Next Earning date - 07 May 2025
Relative Strenght
68Volume Buzz
-96%Earning Acce
NoDist 52w H.
3%